These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9925663)

  • 1. Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids/free cholesterol ratio and of the hdl size distribution.
    Davit-Spraul A; Atger V; Pourci ML; Hadchouel M; Legrand A; Moatti N
    J Lipid Res; 1999 Feb; 40(2):328-35. PubMed ID: 9925663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein pattern and plasma lecithin cholesterol acyl transferase activity in children with Alagille syndrome.
    Gottrand F; Clavey V; Fruchart JC; Farriaux JP
    Atherosclerosis; 1995 Jun; 115(2):233-41. PubMed ID: 7661882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol.
    Davidson WS; Gillotte KL; Lund-Katz S; Johnson WJ; Rothblat GH; Phillips MC
    J Biol Chem; 1995 Mar; 270(11):5882-90. PubMed ID: 7890719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional comparison of HDL from homologous human plasma and follicular fluid. A model for extravascular fluid.
    Jaspard B; Fournier N; Vieitez G; Atger V; Barbaras R; Vieu C; Manent J; Chap H; Perret B; Collet X
    Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1605-13. PubMed ID: 9301642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins.
    Elkhalil L; Majd Z; Bakir R; Perez-Mendez O; Castro G; Poulain P; Lacroix B; Duhal N; Fruchart JC; Luc G
    Metabolism; 1997 May; 46(5):474-83. PubMed ID: 9160810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
    Atger V; de la Llera Moya M; Bamberger M; Francone O; Cosgrove P; Tall A; Walsh A; Moatti N; Rothblat G
    J Clin Invest; 1995 Dec; 96(6):2613-22. PubMed ID: 8675626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.
    Xu B; Gillard BK; Gotto AM; Rosales C; Pownall HJ
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2260-2270. PubMed ID: 29074589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum.
    Fournier N; Paul JL; Atger V; Cogny A; Soni T; de la Llera-Moya M; Rothblat G; Moatti N
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2685-91. PubMed ID: 9409243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system.
    Fournier N; Atger V; Cogny A; Vedie B; Giral P; Simon A; Moatti N; Paul JL
    Atherosclerosis; 2001 Aug; 157(2):315-23. PubMed ID: 11472731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
    Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N
    Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome.
    Yancey PG; Asztalos BF; Stettler N; Piccoli D; Williams DL; Connelly MA; Rothblat GH
    J Lipid Res; 2004 Sep; 45(9):1724-32. PubMed ID: 15210845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acceptor particle size on the efflux of cellular free cholesterol.
    Davidson WS; Rodrigueza WV; Lund-Katz S; Johnson WJ; Rothblat GH; Phillips MC
    J Biol Chem; 1995 Jul; 270(29):17106-113. PubMed ID: 7615505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system.
    Ripollés Piquer B; Nazih H; Bourreille A; Segain JP; Huvelin JM; Galmiche JP; Bard JM
    Metabolism; 2006 Jul; 55(7):980-8. PubMed ID: 16784973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.
    De Vries R; Beusekamp BJ; Kerstens MN; Groen AK; Van Tol A; Dullaart RP
    Scand J Clin Lab Invest; 2005; 65(8):729-37. PubMed ID: 16319046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
    Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
    J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells.
    Cogny A; Atger V; Paul JL; Soni T; Moatti N
    Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):285-92. PubMed ID: 8660296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II.
    Lagrost L; Dengremont C; Athias A; de Geitere C; Fruchart JC; Lallemant C; Gambert P; Castro G
    J Biol Chem; 1995 Jun; 270(22):13004-9. PubMed ID: 7768892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid.
    Jian B; de la Llera-Moya M; Royer L; Rothblat G; Francone O; Swaney JB
    J Lipid Res; 1997 Apr; 38(4):734-44. PubMed ID: 9144088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
    Cheung MC; Mendez AJ; Wolf AC; Knopp RH
    J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.